🇺🇸 FDA
Pipeline program

Dexmedetomidine

UW 15-105

Approved small_molecule active

Quick answer

Dexmedetomidine for Anxiety, Separation is a Approved program (small_molecule) at The University of Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
The University of Hong Kong
Indication
Anxiety, Separation
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials